Stanford Medicine
Sue Siegel has driven game-changing ideas and powered companies that advance industries and improve lives for more than three decades. As GE’s Chief Innovation Officer and CEO of GE Ventures for seven years, Sue oversaw investment in startups, creating and scaling new companies, and commercializing GE’s intellectual property. She also led strategic planning and oversaw the global marketing function.
Before joining GE, Sue was a General Partner at Mohr Davidow Ventures, where she spearheaded investments in personalized medicine, digital health, and life sciences. Prior to becoming a venture capitalist, Sue led Affymetrix as President and a board member. She also held executive leadership roles at Bio-Rad, DuPont, and Amersham after transitioning to a corporate career from early work in molecular biology and biochemistry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Stanford Medicine
Stanford Medicine improves health through leadership, diversity, and collaborative discoveries and innovation in health care, education, and research. The Stanford School of Medicine is a premier setting for integrated research, medical education, and clinical care. As the academic hub of Stanford Medicine, which also comprises adult and pediatric healthcare delivery systems, it fuels discovery and innovation to advance human health while empowering the medical and scientific leaders of tomorrow. Learn more at med.stanford.edu/school.